(Q71787430)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7578528%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

title

Rapid elimination of a high-titer spontaneous factor V antibody by extracorporeal antibody-based immunoadsorption and immunosuppression (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7578528%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7578528%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

author name string

B Tribl

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7578528%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

P Knöbl

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7578528%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

S Kapiotis

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7578528%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

G Aspöck

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7578528%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

U Jäger

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7578528%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

W Hörl

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7578528%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

K Lechner

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7578528%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

publication date

1 October 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7578528%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7578528%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

volume

71

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7578528%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7578528%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

page(s)

199-203

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7578528%20AND%20SRC:MED&resulttype=core&format=json

[Occurrence of a circulating anticoagulant, factor V inhibitor after surgical intervention]

21 October 2019

cites work

1 reference

12 December 2020

Factor V inhibitor and bullous pemphigoid

1 reference

12 December 2020

Massive hemorrhage associated with circulating antibodies to factor V

1 reference

12 December 2020

Successful management of bleeding in a patient with factor V inhibitor by platelet transfusions

1 reference

12 December 2020

Factor V anticoagulants: clinical, biochemical, and immunological observations

1 reference

12 December 2020

Nature of the defect in congenital factor V deficiency: study in a patient with an acquired circulating anticoagulant

1 reference

12 December 2020

A Specific Inhibitor of Human Clotting Factor V

1 reference

12 December 2020

A circulating anticoagulant against factor V

1 reference

12 December 2020

Immune complexes containing factor V in a patient with an acquired neutralizing antibody

1 reference

12 December 2020

[Factor V inhibitor with double cancer]

1 reference

12 December 2020

Antibody-based immunoadsorption as a therapeutic means.

1 reference

12 December 2020

Development of antithrombin antibodies following surgery in patients with prosthetic cardiac valves.

1 reference

12 December 2020

Factor V antibody and disseminated intravascular coagulation

1 reference

12 December 2020

Immunization by bovine thrombin used with fibrin glue during cardiovascular operations. Development of thrombin and factor V inhibitors

1 reference

12 December 2020

Hemorrhagic syndrome caused by a circulating antifactor V anticoagulant. Correction by transfusion of fresh frozen plasma and plasma exchange

1 reference

12 December 2020

[Factor V inhibitor developing in a patient with pulmonary tuberculosis (author's transl)]

1 reference

12 December 2020

Letter: A more uniform measurement of factor VIII inhibitors

1 reference

12 December 2020

Elimination of acquired factor VIII antibodies by extracorporal antibody-based immunoadsorption (Ig-Therasorb)

1 reference

12 December 2020

Clinical Significance of Antibodies to Bovine and Human Thrombin and Factor V After Surgical Use of Bovine Thrombin

1 reference

12 December 2020

A circulating anticoagulant specific for factor V

1 reference

12 December 2020

Inhibitor to factor V in severe factor V congenital deficiency. A case report

1 reference

12 December 2020

The response of an acquired Factor V inhibitor to activated Factor IX concentrate

1 reference

12 December 2020

Observations on a Factor-V Inhibitor

1 reference

12 December 2020

Bovine thrombin-induced inhibitor of factor V and bleeding risk in postoperative neurosurgical patients. Report of three cases

1 reference

12 December 2020

Isolation and study of an acquired inhibitor of human coagulation factor V.

1 reference

12 December 2020

A spontaneous factor V inhibitor with unexpected laboratory features

1 reference

12 December 2020

Factor V inhibitor associated with immune complex formation.

1 reference

12 December 2020

Severe bleeding caused by an inhibitor to coagulation factor V: a case report

1 reference

12 December 2020

A case of factor V inhibitor.

1 reference

12 December 2020

Proceedings: A high titre circulating inhibitor of human factor V: clinical, biochemical and immunological features and its treatment by plasmapheresis

1 reference

12 December 2020

Acquired factor V inhibitor treated with intravenous immunoglobulins

1 reference

12 December 2020

Postextraction bleeding in a patient with an acquired circulating anticoagulant against factor V

1 reference

12 December 2020

Factor V Inhibitor: Report of a Case, with Comments on a Possible Effect of Streptomycin

1 reference

12 December 2020

Factor V inhibitor developing after liver transplantation in a 3-year-old child

1 reference

12 December 2020

Factor V inhibitor in thrombosis

1 reference

12 December 2020

Inhibitor to factor V after exposure to fibrin sealant during cardiac surgery in a two-year-old child

1 reference

12 December 2020

A Circulating Factor V Inhibitor: Possible Side Effect of Treatment with Streptomycin

1 reference

12 December 2020

Bleeding due to an acquired inhibitor of platelet associated factor V

1 reference

12 December 2020

Development of antibodies to thrombin and factor V with recurrent bleeding in a patient exposed to topical bovine thrombin

1 reference

12 December 2020

Hemorrhagic death associated with a high titer factor V inhibitor

1 reference

12 December 2020

An inhibitor against factor V occurring postoperatively in a case of pancreatic cancer

1 reference

12 December 2020

[A circulating inhibitor specific to factor V. Clinical, biological and therapeutic study (author's transl)]

1 reference

12 December 2020

A circulation inhibitor (anti-AcG) specific for the labile factor-V of the blood-clotting mechanism

1 reference

12 December 2020

[A case of sigmoid cancer who acquired factor V inhibitor producibility and treated with factor VIII inhibitor bypassing activity preparation FEIBA--with bibliographic review (author's transl)]

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01910319

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7578528%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference